SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA. 1988;259: 28636.
  • 2
    Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284: 260610.
  • 3
    Covey LS, Glassman AH, Stetner F, Becker JT. Effect of history of alcoholism or major depression on smoking cessation. Am J Psychiatry. 1993;150: 15467.
  • 4
    Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264: 15469.
  • 5
    Hayford KE, Patten CA, Rummans TA, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry. 1999;174: 1738.
  • 6
    Niaura R, Britt DM, Borrelli B, Shadel WG, Abrams DB, Goldstein MG. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999;1: 2517.
  • 7
    Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357: 192932.
  • 8
    Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. Am J Psychiatry. 2000;157: 36874.
  • 9
    Thorsteinsson HS, Gillin JC, Patten CA, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24: 3508.
  • 10
    Hays JT, Hurt RD, Rigotti N, et al. A randomized controlled trial of sustained-release bupropion for pharmacologic relapse prevention following smoking cessation. Ann Intern Med. 2001;135: 42333.
  • 11
    Glynn TJ, Manley MW. How to Help Your Patients Stop Smoking: A National Cancer Institute Manual for Physicians. Bethesda, Md: National Cancer Institute, NIH Publication No. 90-3064; 1990.
  • 12
    Spitzer RL, Williams JBW, Gibbon M, et al. User's Guide for the Structured Clinical Interview for DSM-III-R: SCID. Washington, DC: American Psychiatric Press, Inc.; 1990.
  • 13
    American Psychiatric Association. Diagnostic and Statistical Manual—Revised. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
  • 14
    Swensen WM, Morse RM. The use of a self-administered alcoholism screening test (SAAST) in a medical center. Mayo Clin Proc. 1975; 50: 2048.
  • 15
    Davis LJ. (2000). Self-administered Alcoholism Screening Test (SAAST). In: MaruishME, ed., Handbook of Psychological Assessment in Primary Care Settings. Mahweh, NJ: Lawrence Erlbaum; 2000:53754.
  • 16
    Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3: 23541.
  • 17
    Beck AT, Steer RA. Beck Depression Inventory. Philadelphia, Pa: Center for Cognitive Therapy; 1987.
  • 18
    Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford: Clarendon Press; 1994.
  • 19
    Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73: 1322.
  • 20
    Hays JT, Schroeder DR, Offord KP, et al. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med. 1999;21: 24450.
  • 21
    Hall SM, Reus VI, Munoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998;55: 68390.